Chen Cheng
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Synthesis and biological activity 2
-
- Receptor Mechanisms and Signaling 2
- Co-authors
- Xiaofei Wei (1 shared paper)Na Tang (1 shared paper)Haoyi Wang (1 shared paper)Xingying Zhang (1 shared paper)Weidong Han (1 shared paper)Wei Mu (1 shared paper)Na Li (1 shared paper)Miaomiao Qiao (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (3 papers)Neuropharmacology (2 papers)Journal of the American Chemical Society (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Reproductive Health (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Chen Cheng
19 papers receiving 460 citations
Chen Cheng's Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 271
- Immunology 107
- Anesthesiology and Pain Medicine 21
- Genetics 88
- Molecular Biology 205
Countries citing papers authored by Chen Cheng
This map shows the geographic impact of Chen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Cheng more than expected).
Fields of papers citing papers by Chen Cheng
This network shows the impact of papers produced by Chen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Cheng. The network helps show where Chen Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | TGF-β inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors Hit paper breakdown → | 2020 | 293 |
| 2 | 2008 | 29 | |
| 3 | 1996 | 24 | |
| 4 | 2020 | 22 | |
| 5 | 1992 | 17 | |
| 6 | 2015 | 16 | |
| 7 | 2023 | 14 | |
| 8 | 2018 | 10 | |
| 9 | 1992 | 10 | |
| 10 | 2023 | 7 | |
| 11 | 2024 | 6 | |
| 12 | 2024 | 6 | |
| 13 | 2024 | 4 | |
| 14 | 2020 | 2 | |
| 15 | 1992 | 2 | |
| 16 | 1982 | 2 | |
| 17 | 2020 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2025 | 0 |
About Chen Cheng
Chen Cheng is a scholar working on Organic Chemistry, Molecular Biology, Biomedical Engineering, Pharmacology and Cellular and Molecular Neuroscience, having authored 21 papers that have together received 468 indexed citations. Recurring topics across this work include Chemical Reactions and Isotopes (2 papers), Analytical Chemistry and Chromatography (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Synthesis and biological activity (2 papers), Receptor Mechanisms and Signaling (2 papers), biodegradable polymer synthesis and properties (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Oncology (271 citations), Immunology (107 citations), Anesthesiology and Pain Medicine (21 citations), Genetics (88 citations) and Molecular Biology (205 citations). Chen Cheng has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Xiaofei Wei, Na Tang, Haoyi Wang, Xingying Zhang, Weidong Han, Wei Mu, Na Li, Miaomiao Qiao, Fuu Sheu and Salman Jabri. Their work appears in journals such as Journal of Medicinal Chemistry, Neuropharmacology, Journal of the American Chemical Society, Clinical Pharmacology & Therapeutics and Reproductive Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.